ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
Medium
Risk
Equity
Other
+
20.32
%
20.32
%
3Y annualised
+
0.43
%
0.43
%
1D
1M
6M
1Y
3Y
All
Fund size
3567
NAV:
Mar 7, 2024
30.22
Sector
Tech
Type
Equity
Launched
Jul 2018
Min Investment
5000
Expense Ratio
2
Risk
Medium
Portfolio allocation
Top 10 Holdings
% Value
Sun Pharmaceuticals Industries Ltd
15.92
%
Dr Reddy's Laboratories Ltd
8.76
%
Cipla Ltd
7.05
%
Lupin Ltd
6.33
%
Apollo Hospitals Enterprise Ltd
6.17
%
Aurobindo Pharma Ltd
6.13
%
Mankind Pharma Ltd
2.93
%
Fortis Healthcare Ltd
2.69
%
Alkem Laboratories Ltd
2.66
%
Zydus Lifesciences Ltd
2.63
%
Expense ratio, exit load and tax
Expense Ratio:
2
%
Inclusive of GST
Exit load
Exit load of 1.0% if redeemed within 15.0 Days, 0.0 % if redeemed after 15.0 Days.
Tax implication
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
Fund house & investment objective
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
More details
Investment objective
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.
Scheme Information Document
Mutual Fund investments are subject to market risks. Read all scheme-related documents carefully. Past performance is not an indicator of future returns.
Calculate returns
One-time
Monthly SIP
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
* Returns are calculated as per lifetime average per annum returns of the fund.
Calculate returns
Monthly SIP
One-time
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
